ArticleOncogene2013

Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.

L A Tobin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.